Travere Therapeutics to Report Third Quarter 2023 Financial Results
- Investors can expect to receive an update on Travere Therapeutics' financial performance for Q3 2023, which could positively impact the stock price if the results exceed expectations.
- No negative takes found.
SAN DIEGO, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report third quarter 2023 financial results on Tuesday, November 7, 2023, after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET.
The webcast and dial-in information can be accessed on the Investor page of Travere’s website at ir.travere.com/events-presentations. Following the live webcast, an archived version of the call will be available for 30 days on the Company’s website.
About Travere Therapeutics
At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com.
| Investors: Naomi Eichenbaum Vice President, Investor Relations 888-969-7879 ir@travere.com | Media: Nivi Nehra Vice President, Corporate Communications 888-969-7879 mediarelations@travere.com |
FAQ
When will Travere Therapeutics report its Q3 2023 financial results?
Where can I access the webcast and dial-in information for the conference call?
Will there be an archived version of the conference call available?
